Stay updated on Neoadjuvant Pyrotinib in HER-2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Neoadjuvant Pyrotinib in HER-2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neoadjuvant Pyrotinib in HER-2+ Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    A new revision entry v3.6.6 was added to the record history, replacing the previous v3.6.5 entry. This indicates an update to the page's underlying version rather than changes to the study data.
    Difference
    0.1%
    Check dated 2026-08-31T17:33:51.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    A new revision entry labeled v3.6.5 appears in the record history, replacing the previous v3.6.4.
    Difference
    0.1%
    Check dated 2026-08-10T11:52:41.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The record history shows a new entry: Revision: v3.6.4, replacing Revision: v3.6.3. This is an administrative update to the page's release notes.
    Difference
    0.1%
    Check dated 2026-07-27T05:54:30.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The record history now shows a new revision entry for v3.6.3, indicating a software update to the ClinicalTrials.gov page. This change updates the version label in the history and does not affect the study data or eligibility details.
    Difference
    0.1%
    Check dated 2026-07-05T14:20:25.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    A new revision entry v3.6.2 is added to the study's record history, and the previous revision v3.6.0 is removed from the current history list.
    Difference
    0.1%
    Check dated 2026-06-28T08:30:21.000Z thumbnail image
  9. Check
    93 days ago
    Change Detected
    Summary
    The study's recruitment status changed to 'No longer looking for participants', signaling that enrollment has ended. The record history now includes a new revision tag v3.6.0 and shows the removal of the previous revision tag v3.5.5.
    Difference
    0.5%
    Check dated 2026-06-13T17:52:04.000Z thumbnail image

Stay in the know with updates to Neoadjuvant Pyrotinib in HER-2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neoadjuvant Pyrotinib in HER-2+ Breast Cancer Clinical Trial page.